A new economic model published in the Canadian Journal of Cardiology reveals that integrating pharmacists and nurse practitioners into heart failure care delivers measurable clinical and financial benefits. The analysis demonstrates that pharmacist and nurse practitioner-led medication management extends patient survival, reduces hospitalisation duration, and lowers overall healthcare costs compared to standard physician-only care models.
Heart failure remains one of the most common chronic conditions globally, affecting an estimated 64 million people. Despite the prevalence of the disease, many patients struggle with complex medication regimens, adherence challenges, and gaps in medication optimisation between routine clinic visits. The study suggests that expanding the care team with clinical pharmacists and nurse practitioners addresses these gaps effectively.
Healthcare systems seeking to strengthen their heart failure programmes now have evidence-based support for adopting interprofessional approaches. These findings offer a practical blueprint for scaling team-based medication management across diverse healthcare settings.
Was this article helpful?
